Мітральний стеноз

В.І. Павлюк

Література 

1. Pavlyuk VI. Practical echocardiography. Ed. by О.J. Zharinov. Lviv: Medycina svitu, 2014. 156 p. (in Ukr.).
2. Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum’s Echocardiography. Lippincott Williams & Wilkins, 2010. 785 p.
3. Arora R, Kalra GS, Singh S, et al. Percutaneous transvenous mitral commissurotomy: immediate and long-term follow-up results. Catheter Cardiovasc. Interv. 2002;55:450-456.
4. Baumgartner H, Hung J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J. Am. Soc. Echocardiogr. 2009;22:1-23.
5. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J. Am. Coll. Cardiol. 2006;48:e1-148.
6. Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-437.
7. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA. 1993;270:1731-1736.
8. Chandrashekhar Y. Secondary prevention in rheumatic fever and rheumatic heart disease: theory, practice and meta-analysis of available trials. A textbook of rheumatic fever / Eds. by Narula J, Virmani R, Reddy KS, Tandon RK. Washington, DC: Armed Forces Institute Press, 1999:299-342.
9. Chandrashekhar Y, et al. Mitral stenosis. Lancet. 2009;374:1271-1283.
10. Golbasi Z, Ucar O, Keles T, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail. 2002;4:593-595.
11. Hu CL, Jiang H, Tang QZ, et al. Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study. Heart. 2006;92:1096-1101.
12. Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon Catheter. J Thorac Cardiovasc Surg. 1984;87:394-402.
13. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;13:1231-1243.
14. Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation. 1996;94:2124-2130.
15. Iung B, Gohlke-Barwolf C, Tornos P, et al. Recommendations in the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002;23:1253-1266.
16. Iung B, Nicoud-Houel A, Fondard O, et al. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J. 2004;25:701-707.
17. Kawanishi DT, Kotlewski A, McKay CR, et al. The relative value of clinical examination, echocardiography with doppler and cardiac catheterization with angiography in the evaluation of mitral valve disease. Surgery for heart valve disease / Ed. E. Bodnar. London: ICR Publishers, 1990:73-78.
18. Labovitz AJ, Nelson JG, Windhorst DM, et al. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography. Am J Cardiol. 1985;55:133.
19. Li M, Dery JP, Dumesnil JG, et al. Usefulness of measuring net atrioventricular compliance by Doppler echocardiography in patients with mitral stenosis. Am J Cardiol. 2005;96:432-435.
20. Maganti K, et al. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85:483-500.
21. Magne J, Mathieu P, Dumesnil JG, et al. Impact of prosthesis patient mismatch in survival after mitral replacement. Circulation. 2007;115:1417-1425.
22. Mahoney PD, Loh E, Blitz LR, et al. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension. Am. J. Cardiology. 2001;87:188-192.
23. Matsuyama K, Matsumoto M, Sugita T, et al. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg. 2003;75:1826-1828.
24. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
25. Padmavati S. Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J. 2001;53:35-37.
26. Rapp AH, Cigarroa JE, Lange RA, et al. Hemodynamic characteristics and procedural outcome of patients with mitral stenosis and a depressed cardiac output. Am J Cardiol. 2001;88:1212-1213.
27. Roberts WC, Perloff JK. Mitral valvular disease a clinicopathologic survey of the conditions causing the mitral valve to function аbnormally. Ann Intern Med. 1972;77:939-975.
28. Sagie A, Schwammenthal E, Palacios IF, et al. Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy. J. Thorac Cardiovasc Surg. 1994;108:727-735.
29. Serraf A, Zoghbi J, Belli E, et al. Congenital mitral stenosis with or without associated defects: an evolving surgical strategy. Circulation. 2000;102:166-171.
30. Song JK, Kang DH, Lee WE, et al. Factors determining the exercise capacity in mitral stenosis. Am J Cardiol. 1996;78:1060-1062.
31. Song H, Kang DH, Kim JH, et al. Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation. 2007;116(Suppl):I246-250.
32. Tamai J, Yoshioka T, Yasuda S, et al. Increase in peak oxygen uptake by restoration of atrial contraction in patients after percutaneous transvenous mitral commissurotomy. J Heart Valve Dis. 1993;2:623-628.
33. Vora A, Karnad D, Goyal V, et al. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study. Indian Heart J. 2004;56:110-116.
34. Yamamoto K, Ikeda U, Mito H, et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation. 1994;89:2093-2098.